Search
Patexia Research
Case number 2018-1849

Intra-Cellular Therapies, Inc v. Iancu > Documents

Date Field Doc. No.Description (Pages)
Apr 23, 2021 0 INTRA-CELLULAR THERAPIES, INC v. IANCU [OPINION - PRECEDENTIAL] [precedential] (0)
Nov 12, 2019 48 Mandate issued to the United States District Court for the Eastern District of Virginia. Service as of this date by the Clerk of Court. [648588] [JAB] [Entered: 11/12/2019 11:31 AM] (2)
Sep 18, 2019 47 JUDGMENT. AFFIRMED. Terminated on the merits after oral argument. COSTS: No Costs. Mandate to issue in due course. For information regarding costs, petitions for rehearing, and petitions for writs of certiorari click here. [636306] [JAB] [Entered: 09/18/2019 09:49 AM] (2)
Sep 18, 2019 46 OPINION filed for the court by Wallach, Circuit Judge; Chen, Circuit Judge and Hughes, Circuit Judge. Precedential Opinion. [636305] [JAB] [Entered: 09/18/2019 09:48 AM] (22)
Jul 16, 2019 45 MODIFIED ENTRY: RESPONSE of Appellee Iancu to the supplemental authority [44] filed by Appellant Intra-Cellular Therapies, Inc.. Service: 07/16/2019 by email. [621461]--[Edited 07/17/2019 by JCA - Reason: to correct filing event] [Andrew Han] [Entered: 07/16/2019 07:05 PM] (2)
Jul 2, 2019 44 Citation of Supplemental Authority pursuant to Fed. R. App. P. 28(j) for Appellant Intra-Cellular Therapies, Inc.. Service: 07/02/2019 by email. [618682] [18-1849] [Thomas Hoxie] [Entered: 07/02/2019 04:10 PM] (2)
Feb 6, 2019 43 Submitted after ORAL ARGUMENT by Thomas Hoxie, for Intra-Cellular Therapies, Inc. and Andrew Sun Han for Iancu. Panel: Judge: Wallach , Judge: Chen , Judge: Hughes. [583754] [PBC] [Entered: 02/06/2019 11:57 AM] (0)
Feb 4, 2019 42 Citation of Supplemental Authority pursuant to Fed. R. App. P. 28(j) for Appellant Intra-Cellular Therapies, Inc.. Service: 02/04/2019 by email, US mail. [583177] [18-1849] [Thomas Hoxie] [Entered: 02/04/2019 02:16 PM] (2)
Jan 16, 2019 41 Notice of Appointment of New Solicitor for the U.S. Patent and Trademark Office. Service: 01/24/2019 by clerk. [580682] [16-2222, 17-1666, 17-1732, 17-2052, 17-2054, 17-2292, 17-2294, 17-2465, 17-2503, 17-2543, 17-2565, 17-2579, 17-2620, 17-2624, 18-1060, 18-1065, 18-1067, 18-1077, 18-1154, 18-1166, 18-1172, 18-1173, 18-1242, 18-1426, 18-1557, 18-1595, 18-1773, 18-1795, 18-1828, 18-1847, 18-1849, 18-1895, 18-1958, 18-1995, 18-2090] [JAB] [Entered: 01/24/2019 03:27 PM] (1)
Jan 8, 2019 40 Response to notice of oral argument from the Appellee Iancu. [576617] [18-1849] [Andrew Han] [Entered: 01/08/2019 11:28 AM] (3)
Jan 4, 2019 39 Response to notice of oral argument from the Appellant Intra-Cellular Therapies, Inc.. [576085] [18-1849] [Thomas Hoxie] [Entered: 01/04/2019 05:25 PM] (3)
Dec 17, 2018 38 NOTICE OF ORAL ARGUMENT. Panel: 1902G. Case scheduled Feb 06, 2019 10:00 a.m. at the United States Court of Appeals for the Federal Circuit (Howard T. Markey National Courts Building, 717 Madison Place, NW Washington, DC 20439), Courtroom 201. Response to Notice of Oral Argument due: 01/15/2019. Please review the attached Notice. The response to notice of oral argument form can be found here. The Oral Argument Guide can be found here. [572227] [JAB] [Entered: 12/17/2018 02:22 PM] (2)
Oct 19, 2018 37 Notice from Appellant Intra-Cellular Therapies, Inc. regarding conflicts with oral argument (I have a conflict for oral argument in this case from November 12, 2018 to November 15, 2018, and from January 28, 2019 to January 30, 2019.). Service: 10/19/2018 by email, US mail. [558849] [18-1849] [Thomas Hoxie] [Entered: 10/19/2018 04:12 PM] (1)
Oct 19, 2018 36 Notice from Appellant Intra-Cellular Therapies, Inc. regarding conflicts with oral argument (I write to notify the Court that I have a conflict for oral argument in this case on December 7, 2018 (scheduled oral hearing in U.S. District Court for the Eastern District of Virginia).). Service: 10/19/2018 by email, US mail. [558779] [18-1849] [Thomas Hoxie] [Entered: 10/19/2018 02:01 PM] (1)
Sep 17, 2018 35 Notice from Appellee Iancu regarding conflicts with oral argument (November 5, 2018 through November 9, 2018). Service: 09/17/2018 by email. [550487] [18-1849] [Andrew Han] [Entered: 09/17/2018 04:36 PM] (3)
Sep 17, 2018 34 Notice from Appellant Intra-Cellular Therapies, Inc. regarding conflicts with oral argument (I have a conflict for oral argument in this case on September 27, 2018 and October 18 to October 25, 2018.). Service: 09/17/2018 by email. [550434] [18-1849] [Thomas Hoxie] [Entered: 09/17/2018 03:37 PM] (1)
Sep 14, 2018 33 6 paper copies of the appendix Brief [31] received from Appellant Intra-Cellular Therapies, Inc. [550040] [SJL] [Entered: 09/14/2018 04:31 PM] (0)
Sep 10, 2018 32 Pursuant to Practice Note 34, counsel should advise the clerk of court of scheduling conflicts for the next three court weeks, or thereafter. When filing the notice of conflicts, counsel should docket the Notice Regarding Conflicts with Argument Dates event, which is found in the Calendar event category. The notice of conflict with oral argument is due on or before 09/17/2018. [548508] [JB] [Entered: 09/10/2018 03:52 PM] (0)
Sep 5, 2018 30 6 paper copies of the Reply Brief [26] received from Appellant Intra-Cellular Therapies, Inc.. [547325] [CJF] [Entered: 09/05/2018 12:42 PM] (0)
Sep 4, 2018 31 CORRECTED APPENDIX FILED for Intra-Cellular Therapies, Inc. [29]. Number of Pages: 259. Service: 09/04/2018 by email. The paper copies of the brief should be received by the court on or before 09/17/2018. [548507] [JB] [Entered: 09/10/2018 03:50 PM] (259)
Sep 4, 2018 29 TENDERED from Appellant Intra-Cellular Therapies, Inc.. Title: CORRECTED JOINT APPENDIX. Service: 09/04/2018 by email. [547158] [18-1849] [Thomas Hoxie] [Entered: 09/04/2018 07:24 PM] (259)
Sep 4, 2018 28 NOTICE OF NON-COMPLIANCE: The submission of Appellant Intra-Cellular Therapies, Inc., Joint Appendix [27], is not in compliance with the rules of this court (see attached). Corrected Appendix due 09/11/2018. Service as of this date by the Clerk of Court.[547058] [JB] [Entered: 09/04/2018 04:04 PM] (1)
Aug 30, 2018 27 TENDERED from Appellant Intra-Cellular Therapies, Inc.. Title: JOINT APPENDIX. Service: 08/30/2018 by email. [546534] [18-1849] This document is non-compliant. See Doc No.[28] [Thomas Hoxie] [Entered: 08/30/2018 04:27 PM] (0)
Aug 23, 2018 25 TENDERED from Appellant Intra-Cellular Therapies, Inc.. Title: REPLY BRIEF. Service: 08/23/2018 by email. [545145] [18-1849] [Thomas Hoxie] [Entered: 08/23/2018 07:03 PM] (41)
Aug 23, 2018 26 REPLY BRIEF FILED for Appellant Intra-Cellular Therapies, Inc. [25]. Number of Pages: 33. Service: 08/23/2018 by email. The paper copies of the brief should be received by the court on or before 09/05/2018. Appendix is due 08/30/2018. [545908] [JB] [Entered: 08/28/2018 04:02 PM] (41)
Aug 20, 2018 24 6 paper copies of the Opening Response Brief [23] received from Appellee Iancu. [544134] [CJF] [Entered: 08/20/2018 03:43 PM] (0)
Aug 10, 2018 23 BRIEF FILED for Appellee Iancu [22]. Number of Pages: 53. Service: 08/10/2018 by email. The paper copies of the brief should be received by the court on or before 08/23/2018. Appellant Intra-Cellular Therapies, Inc. reply brief is due 08/24/2018. [543292] [JB] [Entered: 08/16/2018 09:19 AM] (64)
Aug 10, 2018 22 TENDERED from Appellee Iancu. Title: RESPONSE BRIEF. Service: 08/10/2018 by email. [542262] [18-1849] [Andrew Han] [Entered: 08/10/2018 08:28 PM] (64)
Aug 10, 2018 21 Entry of appearance for Joseph Matal as of counsel for Appellee Iancu. Service: 08/10/2018 by email. [542084] [18-1849] [Joseph Matal] [Entered: 08/10/2018 01:12 PM] (2)
Jul 19, 2018 20 Notice of Withdrawal of Director's Counsel - Nathan K. Kelley. Service: 07/19/2018 by clerk. [536940] [18-1167, 18-1171, 18-1285, 18-1286, 18-1289, 18-1595, 18-1609, 18-1633, 18-1651, 18-1659, 18-1710, 18-1711, 18-1712, 18-1714, 18-1730, 18-1772, 18-1773, 18-1828, 18-1847, 18-1876, 18-1883, 18-1901, 18-1998, 18-2017, 18-2048, 18-2049, 17-1765, 17-1825, 17-2292, 17-2294, 17-2392, 17-2465, 17-2543, 17-2047, 17-2620, 18-1071, 18-1172, 18-1173, 18-1557, 18-1593, 18-1795, 18-1895, 18-2000, 17-2122, 17-2124, 17-2239, 17-2241, 18-1013, 18-1047, 18-1048, 18-1070, 18-1242, 18-1353, 18-1849, 18-1958, 18-1992, 18-1994, 18-1995, 18-2043, 17-2364, 17-2579, 17-2580, 17-2593, 17-2594, 18-1067, 18-1069, 18-1077, 18-1163, 18-1166, 18-1253, 18-1311, 18-1368, 18-1385, 18-1426, 18-1944, 18-1968, 18-2031, 18-2032, 18-2069, 18-2106, 17-2503, 17-2624, 18-1000, 18-1060, 18-1065, 18-1066, 18-1416, 18-1461, 18-2090, 15-1242, 15-1944, 15-1945, 15-1946, 16-1794, 16-2222, 16-2470, 16-2548, 16-2640, 16-2669, 16-2736, 17-1159, 17-1265, 17-1266, 17-1268, 17-1362, 17-1425, 17-1486, 17-1578, 17-1582, 17-1629, 17-1666, 17-1722, 17-1827, 17-1849, 17-1870, 17-1953, 17-1954, 17-1955, 17-1957, 17-1962, 17-1963, 17-2037, 17-2038, 17-2069, 17-2208, 17-2232, 17-2244, 17-2255, 17-2263, 17-2361, 17-2424, 17-2426, 17-2447, 17-2524, 18-1085, 18-1088, 18-1122] [TAR] [Entered: 07/19/2018 10:11 AM] (2)
Jul 3, 2018 19 CLERK'S OFFICE QUALITY CONTROL MESSAGE: ERROR: motion to extend time to file brief [17] did not contain the required certificate of compliance with the word count. CORRECTION: Pursuant to FRAP 32(g)(1), motions must contain a certificate of compliance with the word count. Please ensure future motions include the certificate of compliance. THIS MESSAGE IS FOR INFORMATIONAL PURPOSES ONLY. [533440] [JB] [Entered: 07/03/2018 12:15 PM] (0)
Jul 3, 2018 18 **TEXT ONLY** ORDER granting motion to extend time to file brief [17] filed by Appellee Iancu. Appellee Andrei Iancu, Director, U.S. Patent and Trademark Office brief is due on 08/10/2018. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [533439] [JB] [Entered: 07/03/2018 12:13 PM] (0)
Jul 2, 2018 17 MOTION of Appellee Iancu to extend the time to 08/10/2018 to file the defendant-appellee's principal brief. [Consent: unopposed]. Service: 07/02/2018 by email. [533236] [18-1849] [Andrew Han] [Entered: 07/02/2018 05:42 PM] (5)
Jun 25, 2018 16 6 paper copies of the Opening Brief [15] received from Appellant Intra-Cellular Therapies, Inc.. [531623] [CJF] [Entered: 06/25/2018 11:00 AM] (0)
Jun 15, 2018 15 BRIEF FILED for Appellant Intra-Cellular Therapies, Inc. [14]. Number of Pages: 43. Service: 06/15/2018 by email. The paper copies of the brief should be received by the court on or before 06/26/2018. Appellee Andrei Iancu, Director, U.S. Patent and Trademark Office brief is due 07/25/2018. [530470] [JB] [Entered: 06/19/2018 09:41 AM] (67)
Jun 15, 2018 14 TENDERED from Appellant Intra-Cellular Therapies, Inc.. Title: OPENING BRIEF. Service: 06/15/2018 by email. [530058] [18-1849] [Thomas Hoxie] [Entered: 06/15/2018 08:50 PM] (67)
May 31, 2018 13 REMINDER: All counsel of record are reminded of their responsibility per Fed. Cir. R. 47.4(a)and Fed. Cir. R. 47.3 to promptly submit an amended Certificate of Interest (COI) and/or Entry of Appearance (EOA) as information changes during the pendency of the appeal. Failure to comply with these Rules may delay the timely processing of your case or result in adverse action. [525683] [JB] [Entered: 05/31/2018 08:21 AM] (0)
May 18, 2018 12 Docketing Statement for the Appellee Iancu. Service: 05/18/2018 by email. [523006] [18-1849] [Andrew Han] [Entered: 05/18/2018 04:17 PM] (3)
May 17, 2018 11 Entry of appearance for Nathan K. Kelley as of counsel for Appellee Iancu. Service: 05/17/2018 by email. [522594] [18-1849] [Nathan Kelley] [Entered: 05/17/2018 03:28 PM] (2)
May 17, 2018 10 Entry of appearance for Thomas W. Krause as of counsel for Appellee Iancu. Service: 05/17/2018 by email. [522591] [18-1849] [Thomas Krause] [Entered: 05/17/2018 03:26 PM] (2)
May 4, 2018 9 Corrected Certificate of Interest for the Appellant Intra-Cellular Therapies, Inc.. Service: 05/04/2018 by email. [519417] [18-1849] [Thomas Hoxie] [Entered: 05/04/2018 04:52 PM] (3)
May 4, 2018 8 NOTICE OF DEFICIENCY: The certificate of interest Document No. [5] filed by Appellant Intra-Cellular Therapies, Inc. in 18-1849 is incomplete [see question 5] and therefore cannot be accepted for filing at this time. . Question 5 may not be left blank; if applicable "none" or "n/a" may be used. You are being afforded the opportunity to correct the deficiency. At the discretion of the court, the corrected document may be accepted for filing if received before midnight (EST) on the date of this notice. [519061] [JB] [Entered: 05/04/2018 09:00 AM] (0)
May 3, 2018 7 Entry of appearance for Brian Racilla as of counsel for Appellee Iancu. Service: 05/03/2018 by email. [518773] [18-1849] [Brian Racilla] [Entered: 05/03/2018 12:33 PM] (2)
May 2, 2018 6 Entry of appearance for Andrew S. Han as principal counsel for Appellee Iancu. Service: 05/02/2018 by email. [518633] [18-1849] [Andrew Han] [Entered: 05/02/2018 06:09 PM] (1)
May 2, 2018 5 Certificate of Interest for the Appellant Intra-Cellular Therapies, Inc.. Service: 05/02/2018 by email. [518621] [18-1849] [Thomas Hoxie] [Entered: 05/02/2018 05:11 PM] (0)
May 2, 2018 4 Docketing Statement for the Appellant Intra-Cellular Therapies, Inc.. Service: 05/02/2018 by email. [518619] [18-1849] [Thomas Hoxie] [Entered: 05/02/2018 05:08 PM] (4)
Apr 27, 2018 3 Transcript Purchase Order Form for the Appellant Intra-Cellular Therapies, Inc. indicating that a transcript is not needed for the appeal. Service: 04/27/2018 by email. [517519] [18-1849] [Thomas Hoxie] [Entered: 04/27/2018 05:38 PM] (2)
Apr 27, 2018 2 Entry of appearance for Thomas Hoxie as principal counsel for Appellant Intra-Cellular Therapies, Inc.. Service: 04/27/2018 by email. [517517] [18-1849] [Thomas Hoxie] [Entered: 04/27/2018 05:31 PM] (2)
Apr 18, 2018 1 Appeal docketed. Received: 04/16/2018. [514914]Entry of Appearance due 05/02/2018. Certificate of Interest is due on 05/02/2018. Docketing Statement due 05/18/2018. Appellant/Petitioner's brief is due 06/18/2018. [JB] [Entered: 04/18/2018 02:30 PM] (24)
Menu